Chemical andropause and amyloid-beta peptide

JAMA. 2001 May 2;285(17):2195-6. doi: 10.1001/jama.285.17.2195-a.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / therapy
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Amyloid beta-Peptides / blood*
  • Androgen Antagonists / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Estradiol / blood*
  • Flutamide / therapeutic use
  • Gonadotropin-Releasing Hormone / agonists
  • Humans
  • Leuprolide / therapeutic use
  • Male
  • Middle Aged
  • Neoplasms, Hormone-Dependent / blood
  • Neoplasms, Hormone-Dependent / therapy
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / therapy
  • Testosterone / blood*

Substances

  • Amyloid beta-Peptides
  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Estradiol
  • Flutamide
  • Leuprolide